The Effects of GLP-1 Receptor Agonists on Lean Body Mass Loss & Associated Outcomes in Clinical Trials
Time: 2:00 pm - 2:30 pm
day: Day One
Details:
- Navigating the rationale behind using GLP-1s to treat obesity, MASH and fatty liver disease
- Understanding the limitations of GLP-1 monotherapy and GLP-1/GIP dual agonists
- Strategies to increase the lean body mass retention of GLP-1 patients
